Dec 18 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* MAYNE PHARMA GROUP LTD - ANNOUNCES US COMMERCIAL RIGHTS FOR SUBA-ITRACONAZOLE IN BASAL CELL CARCINOMA NEVUS SYNDROME
Dec 18 (Reuters) - Mayne Pharma Group Ltd MYX.AX :
* MAYNE PHARMA GROUP LTD - ANNOUNCES US COMMERCIAL RIGHTS FOR SUBA-ITRACONAZOLE IN BASAL CELL CARCINOMA NEVUS SYNDROME